TapImmune prices $70M private stock deal at $4; shares down 9% premarket

|By:, SA News Editor

TapImmune (NASDAQ:TPIV) slips 9% premarket on the heels of its announced private placement of 17.5M common shares at $4/share. Investors will also receive five-year warrants to purchase up to 13.125M shares at $5.

The transaction should close by the end of next quarter.

Yesterday's close was $5.95.

Subscribe for full text news in your inbox